Envestnet Asset Management
DNLI icon

Envestnet Asset Management’s Denali Therapeutics DNLI Stock Holding History

Envestnet Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
51,424
+524
+1% +$10.8K ﹤0.01% 3446
2026
Q1 		$977K Buy
50,900
+12,231
+32% +$243K ﹤0.01% 3481
2025
Q4 		$638K Buy
38,669
+6,254
+19% +$106K ﹤0.01% 3546
2025
Q3 		$471K Sell
32,415
-1,123
-3% -$16.1K ﹤0.01% 3802
2025
Q2 		$469K Buy
33,538
+2,108
+7% +$29.7K ﹤0.01% 3734
2025
Q1 		$427K Sell
31,430
-6,192
-16% -$119K ﹤0.01% 3712
2024
Q4 		$767K Buy
37,622
+9,643
+34% +$247K ﹤0.01% 3333
2024
Q3 		$815K Buy
27,979
+6,838
+32% +$169K ﹤0.01% 3250
2024
Q2 		$491K Sell
21,141
-1,155
-5% -$22.2K ﹤0.01% 3470
2024
Q1 		$458K Sell
22,296
-1,265
-5% -$23.8K ﹤0.01% 3497
2023
Q4 		$506K Buy
23,561
+440
+2% +$8.71K ﹤0.01% 3319
2023
Q3 		$477K Buy
23,121
+7,498
+48% +$190K ﹤0.01% 3281
2023
Q2 		$461K Sell
15,623
-25,814
-62% -$726K ﹤0.01% 3259
2023
Q1 		$955K Buy
41,437
+520
+1% +$14.3K ﹤0.01% 2705
2022
Q4 		$1.14M Sell
40,917
-599
-1% -$17.8K ﹤0.01% 2542
2022
Q3 		$1.27M Buy
41,516
+11,073
+36% +$360K ﹤0.01% 2368
2022
Q2 		$896K Sell
30,443
-2,915
-9% -$76.4K ﹤0.01% 2681
2022
Q1 		$1.07M Buy
33,358
+4,795
+17% +$165K ﹤0.01% 2610
2021
Q4 		$1.27M Buy
28,563
+2,312
+9% +$110K ﹤0.01% 2463
2021
Q3 		$1.32M Buy
+26,251
New +$1.48M ﹤0.01% 2360

Other funds holding DNLI

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Envestnet Asset Management's DNLI Position: Q2 2026 in Review

Envestnet Asset Management increased its Denali Therapeutics (DNLI) stake by 1% in Q2 2026, buying an estimated $10.8K and bringing the position to 51,424 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3446.

Envestnet Asset Management first reported a position in DNLI in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.32M in Q3 2021. 73 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Envestnet Asset Management held 51,424 shares of Denali Therapeutics worth $1.32M as of Q2 2026.
  • Envestnet Asset Management bought 524 Denali Therapeutics shares in Q2 2026, an estimated $10.8K.
  • Denali Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3446 holding.
  • Envestnet Asset Management first reported a position in Denali Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Envestnet Asset Management's Denali Therapeutics position peaked at $1.32M in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.